Trials / Completed
CompletedNCT02004613
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 798 (actual)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Detailed description
The investigator goal is to evaluate the effects of intraoperative and postoperative dexmedetomidine sedation (versus placebo after cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Dexmedetomidine |
| DRUG | Placebo | Normal saline administration matching dexmedetomidine rate of infusion |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2018-12-01
- Completion
- 2020-12-18
- First posted
- 2013-12-09
- Last updated
- 2021-04-06
- Results posted
- 2021-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02004613. Inclusion in this directory is not an endorsement.